These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3905751)

  • 61. CA 125 in peritoneal fluid from patients with endometriosis.
    Moen MH; Hagen B; Onsrud M
    Hum Reprod; 1991 Nov; 6(10):1400-3. PubMed ID: 1770134
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tissue levels in patients after intravenous administration of ceftazidime.
    Loebis LH
    J Antimicrob Chemother; 1985 Dec; 16(6):757-61. PubMed ID: 3912366
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intraperitoneal cefazolin and ceftazidime effects on human peritoneal mesothelial cell release of cancer antigen-125.
    Manley HJ; Elwell RJ; Bailie GR; Welch CL
    Ann Pharmacother; 2004 Dec; 38(12):2035-40. PubMed ID: 15536141
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ceftazidime: experimental and clinical evaluation of biliary elimination.
    Brogard JM; Jehl F; Monteil H; Blickle JF; Arnaud JP
    Drugs Exp Clin Res; 1987; 13(2):105-14. PubMed ID: 3556121
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ceftazidime in the treatment of Pseudomonas infections in intensive-care patients.
    Rondanelli R; Dionigi RV; Regazzi MB; Maurelli M; Calvi M; Mapelli A
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):457-9. PubMed ID: 3536763
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Significance of intraperitoneal administration of antibiotics in abdominal surgery (author's transl)].
    Ota H; Oguchi Y; Sakaguchi H; Shu A; Ozawa M
    Jpn J Antibiot; 1975 Apr; 28(2):132-6. PubMed ID: 1097760
    [No Abstract]   [Full Text] [Related]  

  • 67. Pharmacokinetic profiles of ceftazidime in cochlear perilymph, cerebrospinal fluid and plasma: a high-performance liquid chromatographic study.
    Sun AH; Parnes LS; Freeman DJ
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):256-9. PubMed ID: 8587777
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biochemical analysis of peritoneal fluid in patients with and without bacterial infection.
    Simmen HP; Battaglia H; Giovanoli P; Hänseler E; Blaser J
    Eur J Surg; 1995 Jan; 161(1):23-7. PubMed ID: 7727601
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The kinetics of cefuroxime in ascitic and pleural fluid.
    Lechi A; Arosio E; Xerri L; Mengoli C; Montesi G; Ghidini O
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):493-6. PubMed ID: 6815108
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of hemodialysis on ceftazidime pharmacokinetics.
    Nikolaidis P; Tourkantonis A
    Clin Nephrol; 1985 Sep; 24(3):142-6. PubMed ID: 3899438
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elevated angiogenin levels in the peritoneal fluid of women with endometriosis correlate with the extent of the disorder.
    Suzumori N; Zhao XX; Suzumori K
    Fertil Steril; 2004 Jul; 82(1):93-6. PubMed ID: 15236995
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis.
    Stass H; Rink AD; Delesen H; Kubitza D; Vestweber KH
    J Antimicrob Chemother; 2006 Sep; 58(3):693-6. PubMed ID: 16895940
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid.
    Walstad RA; Hellum KB; Blika S; Dale LG; Fredriksen T; Myhre KI; Spencer GR
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():275-82. PubMed ID: 6352632
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Penetration of clindamycin and metronidazole into the appendix and peritoneal fluid in children.
    Nagar H; Berger SA; Hammar B; Gorea A
    Eur J Clin Pharmacol; 1989; 37(2):209-10. PubMed ID: 2792177
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Peritoneal and systemic cytokine response to laparotomy.
    Badia JM; Whawell SA; Scott-Coombes DM; Abel PD; Williamson RC; Thompson JN
    Br J Surg; 1996 Mar; 83(3):347-8. PubMed ID: 8665188
    [No Abstract]   [Full Text] [Related]  

  • 76. Sequential ventricular fluid concentrations of ceftazidime--report of three cases.
    Polk RE; Mayhall CG; Tartaglione T; Baggett J; Patterson P
    Drug Intell Clin Pharm; 1984 Dec; 18(12):984-7. PubMed ID: 6391885
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The penetration of cefoxitin into peritoneal fluid.
    Wise R; Donovan IA; Ambrose NS; Allcock JE
    J Antimicrob Chemother; 1981 Dec; 8(6):453-7. PubMed ID: 7333989
    [No Abstract]   [Full Text] [Related]  

  • 78. Concentration-dependent disappearance of fluorouracil from peritoneal fluid in the rat: experimental observations and distributed modeling.
    Collins JM; Dedrick RL; Flessner MF; Guarino AM
    J Pharm Sci; 1982 Jul; 71(7):735-8. PubMed ID: 7120053
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Extraction of ceftazidime in bone.
    Hughes SP; McCarthy ID; Fleming RM; Anderson FM; Dash CH
    J Antimicrob Chemother; 1984 Sep; 14(3):285-9. PubMed ID: 6386787
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Peritoneal contamination from unperforated and uninflamed bowel.
    Pollock AV; Evans M
    J Hosp Infect; 1986 May; 7(3):302-3. PubMed ID: 2873181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.